Published • loading... • Updated
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
The company said a $149 million goodwill charge and weaker North America volumes pushed operating loss to $165.8 million and forced a lower revenue forecast.
- On Tuesday, Azenta, Inc. reported second-quarter results and cut its fiscal 2026 outlook after recording a $149 million non-cash goodwill impairment charge in operating expenses.
- President and CEO of Azenta Life Sciences John Marotta cited "execution gaps and a more cautious demand environment, particularly in North America" for results falling short of expectations.
- Organic revenue declined 3% year-over-year, while the company reported a $165.8 million operating loss for the quarter, driven by weakness in Multiomics and Sample Management Solutions.
- Azenta is increasing operational rigor and strengthening leadership across the organization while extending its long-range financial plan targets by one year to 2029 from 2028.
- For fiscal year ending September 30, 2026, Azenta expects total revenue to range between approximately $603 million and $621 million, reflecting cautious near-term outlook.
Insights by Ground AI
15 Articles
15 Articles
Bennington Banner+14 Reposted by 14 other sources
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
FY'26 total reported revenue from continuing operations to range between approximately $603 to $621 millionFY'26 organic revenue is now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growthFY'26 Adjusted EBITDA…
Coverage Details
Total News Sources15
Leaning Left2Leaning Right2Center6Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 20%
C 60%
R 20%
Factuality
To view factuality data please Upgrade to Premium
